Disease outbreak news
On 11 August 2016, the National Health and Family Planning Commission of China notified WHO of five additional cases of laboratory-confirmed human infection with avian influenza A(H7N9) virus, including one death.
Onset dates ranged from 24 June – 29 July 2016, and three of the five cases are male. Cases ranged in age from 13 – 79 years with a median age of 68 years (among cases reported so far, age range is from 0 – 91 years, with a median age of 58 years).
Two of the five cases reported exposure to live poultry, or were involved in the slaughter of poultry. There was no reported history of exposure to poultry for the other three cases. Cases were reported from two provinces (Fujian and Hebei) and one municipality (Beijing). Cases reported from Hebei and Beijing were reported to be family members. Investigations are on-going, at this stage human-to human-transmission cannot be ruled out, however to date no further transmission has been reported.
A total of 798 laboratory-confirmed human cases with avian influenza A(H7N9) virus have been reported through IHR notification since early 2013.
Public health response
The Chinese Government has taken the following surveillance and control measures:
- strengthening outbreak surveillance and situation analysis;
- reinforcing all efforts on medical treatment; and
- conducting risk communication with the public and dissemination of information.
WHO risk assessment
Most human cases are exposed to the A(H7N9) virus through contact with infected poultry or contaminated environments, including live poultry markets. Since the virus continues to be detected in animals and environments, further human cases can be expected. Although small clusters of human cases with influenza A(H7N9) viruses have been reported including those involving healthcare workers, current epidemiological and virological evidence suggests that this virus has not acquired the ability of sustained transmission among humans. Therefore further community level spread is considered unlikely.
Human infections with the A(H7N9) virus are unusual and need to be monitored closely in order to identify changes in the virus and/or its transmission behaviour to humans as it may have a serious public health impact.